Gts Securities LLC Axsome Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$78.93 - $95.84 $331,506 - $402,528	4,200 Added 18.1%	27,400 $2.46 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $860,932 - $1.05 Million	-13,100 Reduced 36.09%	23,200 $1.87 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $2.75 Million - $3.88 Million	-39,700 Reduced 52.24%	36,300 $2.9 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $1.38 Million - $2.02 Million	24,100 Added 46.44%	76,000 $6.05 Million
Q3 2023 Nov 15, 2023	BUY	$69.25 - $82.21 $3.59 Million - $4.27 Million	51,900 New	51,900 $3.63 Million

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.27B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.